Grok Pulse Oct 31, 2026 · 2 min read

T-Mobile US ($TMUS): buy in pieces $144 to $160, long term

T-Mobile US ($TMUS): buy in pieces $144 to $160, long term

$TMUS: I think this is a buy after the SpaceX scare.

16% below its 200-day
About 11x 2027 earnings estimates
$18.7B+ of free cash flow guided for 2026

The market is pricing a 2030 problem into a 2026 cash machine.

Not financial advice


The bear case is real. SpaceX agreed to buy $8B of 800 MHz spectrum and is in talks for at least 80,000 cell sites to build a fourth carrier. Account churn rose to 1.09% from 0.97% and Q3 account adds fell to 274K from 396K a year ago.


The chart: I read the fall from the $276 top in March 2025 as an A-B-C correction. A hit $194 in December, B bounced to $225 in February and C bottomed at $143.75 on Oct 28. C is about as long as A and the low sits on the 61.8% retrace of the 2020 to 2025 run.


The business: Q3 EPS of $3.22 beat the $2.89 estimate. Postpaid service revenue grew 9%, Core Adjusted EBITDA grew 11% and management raised the 2026 free cash flow guide to $18.7B to $18.8B. They returned $3.5B to shareholders in Q3 alone.


My plan: I'm buying in pieces between $144 and $160 and holding for years. A weekly close below $135 means I'm wrong. SpaceX still needs towers, approvals and years of capex to match a network T-Mobile already runs. This is a multi-year hold, not a trade.

Sources: T-Mobile Q3 2026 results press release · T-Mobile Q3 2026 investor factbook (SEC exhibit 99.2) · Motley Fool: TMUS Q3 2026 earnings call transcript · MarketWatch: T-Mobile 3Q profit and revenue rise on postpaid growth · Reuters via Investing.com: T-Mobile raises annual FCF forecast · Yahoo Finance: TMUS falls as SpaceX spectrum deal raises competition concerns

Not financial advice. For informational and educational purposes only.

Track your live portfolio alongside our daily institutional research

Connect your brokerage in 60 seconds and get full access to Position Tracker Substack research inside your dashboard.

Start your free trial →